Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.9600 (0.03%) ($26.6900 - $29.8000) on Tue. Mar. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.05% (three month average) | RSI | 97 | Latest Price | $28.9600(0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 5% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(58%) IBB(57%) XBI(57%) IWO(54%) ARKK(53%) | Factors Impacting EDIT price | EDIT will decline at least -4.525% in a week (0% probabilities). VIXM(-14%) TLT(-6%) SHY(-6%) GDXJ(-4%) UUP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.525% (StdDev 9.05%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $26.51(9.24%) | 10 Day Moving Average | $23.15(25.1%) | 20 Day Moving Average | $0(0%) | To recent high | 0% | To recent low | 126.1% | Market Cap | $1.799b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |